I noticed the SAVA results today. It’s a small play for me.

I’m still invested in some AD plays including Synaptogenix.

https://irpages2.eqs.com/download/companies/annovis/Presentations/Annovis%20Presentation%20%20February%202024%20v2.pdf

Feb presentation

https://www.clinicalleader.com/doc/was-fda-wrong-annovis-bio-shows-strong-data-and-no-side-effects-0001

Article regarding Annovis is from 2021. It mentions Tau- they have a Parkinson’s read out coming in next 7 weeks and AD second quarter. PD is looking interesting.

SeekingAlpha author is long SAVA and short ANVS. They are feeling some pressure today if they didn’t cover.
Note how a history teachers writes about his favorite AD stock. Anything to get clicks on SA is the name of the game.

https://www.clinicalleader.com/doc/was-fda-wrong-annovis-bio-shows-strong-data-and-no-side-effects-0001

Excerpt from 2021 article regarding Parkinson’s trial.

“I don’t want to sound cocky, but I really do not see any challenges ahead for our Phase 3 trial,” she says. “Patients are required to take one pill a day. It is a small dose with no side effects. I have also heard great feedback from patients. One Parkinson’s patient emailed me a while back. He was in his second Phase 2 trial and was not seeing any improvement. When that trial concluded he was able to try our treatment in a third Phase 2 trial. After just two weeks he contacted me to tell me that it worked. Several other patients did so as well. They reported better memory, coordination, and attention span with less shaking. We believe we will see similar results in our Phase 3 trial. We will present our data to the FDA in September and plan to start the Phase 3 trials for both Alzheimer’s and Parkinson’s this winter.”


Might be the reason CEO and Insiders are buying. A lot of drugs are in clinical for multiple indications but how often do they talk about better cognition as a side effect?? Rett, MS, trials? Several Parkinson’s patients are commenting on cognition.

Nice purchase from the CEO and board.
Board owns over 20% of company and bot more on open market.

The link would not save- a quick search of the video titled “money matters TV 23-24 Maccecchini #4” . Recorded June 2023 is a nice resource.

Money Matters Interview

https://share.transistor.fm/s/a6e1c2ef

Older interview but I like the comment at 14 minute- Goldmine

Thanks, they are really hopeful since
Buntanetap is the only drug to attack multiple neurotoxic proteins.

Best wishes to you.

Have you looked at Annovis bio?

I see you stopped posting on Anavex on a regular. What happened?

SOLD....

buy for $1.6 and sold for $7.9... CASh cow

SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,OLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,SOLD, sold, sold, sold, sold, sold,
SOLD, sold, sold, sold, sold, sold,

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.


SOLD --- turn and burn.. babyyy

wow, he is really turning a profit.. Disposed of at $7.9 a share... turn and burn...

I am sure Misleading is not working for free.. (I used the term work JK) And in June he unloaded a few cheap ones for a nice return..
I made a couple of quarters so it's all good..

Misleading is milking this cash cow.
More delays more money for misleading. Shareholders did okay as well.

I’ll take a check. LOL

Feb 9th was my last buy in the $150’s.
China is starting to mess with my profits. It’s what 20% of overall sales. This week will be interesting. Might buy some put insurance.

Hopefully Annovis Bio is an option for Parkinson’s. We can do without stock options.

No options and hopefully it stays that way.

Good question. On my chart it had a pinbar off of the $161.94 pivot on the hourly. Two hours in the hood so far.

Bears showed up today.

Boy Misleading hit a nerve.

No one.

It tells me know one believes in a 100x, 50x, 25x, 10x, 5x or a 2x return.

For clarification not one is in reference to $14,$15 & $16 strike. The $20 is correct for OI. $4 out is correct with OI over 4,000 and Vol over OI.

The $14 Call vol 91– The $4 Put vol over 4000 and Vol over OI. I say the market is betting on this one. Betting DOWN.

I hope the results are positive but hope is not an investment strategy.

Lol. Not a one of those strikes have OI over 1000 for 12/2. Puts in the multi thousands.

Put buying was aggressive at $4,$5,$6 range. Follow the $. Someone always knows. One order equivalent to 48,000 shares.

That’s even more negative. If market is not participating with the potential returns, that’s even more negative.

No results yet. Lol. Told you in 2019 that there would be no AD results in 2021.
CEOs math was not adding up and but confirmation bias was in full display.

SHOP is dropping.

Some of my buy orders got triggered today as well.

I have a feeling this market is going to take a deeper dive in the weeks to come unless this drop changes the tone at the fed.

Hopefully this sell off continues. I like clear trends and this one has been pretty good. I need to hold my puts a little longer. Kicking myself for selling my $150 PayPal puts too quick. At this point anything with a high PE is game since Microsoft, Google and Apple are looking iffy.

Just wondering how many patients were actually enrolled. “ announced that it has completed enrolling its target of 100 patients for its ongoing National Institutes of Health”.

No biggie, just wondering how much insurance we bought since the announcement took a little longer than “I” anticipated.

$QCOM PE is getting into reasonable area. 16.8 but still top heavy.

Added some at last summer’s support area.

I have some Sept calls you can get on the cheap.